METAVENTION
Metavention develops medical devices to help with interventional therapies for Type 2 diabetes.
METAVENTION
Industry:
Biotechnology Diabetes Health Care
Founded:
2012-01-01
Address:
Eden Prairie, Minnesota, United States
Country:
United States
Website Url:
http://www.metavention.com
Total Employee:
11+
Status:
Active
Contact:
16128148202
Total Funding:
65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Apache Global Site Tag
Current Advisors List
Board_member
2017-08-01
Board_member
Current Employees Featured
Scott Vafai Co-Founder @ Metavention
Co-Founder
2012-01-01
Todd Berg Chief Executive Officer @ Metavention
Chief Executive Officer
2018-01-01
Kavitha Ganesan Director of Regulatory and Advanced Therapies @ Metavention
Director of Regulatory and Advanced Therapies
2019-08-01
Founder
Investors List
Horowitz Group
Horowitz Group investment in Series C - Metavention
Sanderling Ventures
Sanderling Ventures investment in Series C - Metavention
Versant Ventures
Versant Ventures investment in Series C - Metavention
New Enterprise Associates
New Enterprise Associates investment in Series C - Metavention
RK Mellon
RK Mellon investment in Series C - Metavention
Official Site Inspections
http://www.metavention.com Semrush global rank: 8.16 M Semrush visits lastest month: 359
- Host name: 240.112.180.107.host.secureserver.net
- IP address: 107.180.112.240
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Metavention"
Homepage - Metavention
Metavention is a dedicated team with a proven track record of delivering innovative, life-changing therapies to patients and healthcare providers around the world. Everything we do is based on our fundamental belief—do what is …See details»
Company - Metavention
Our company is committed to challenging the status quo to deliver better treatment options to the millions of people who need them. Together, with patients and the healthcare professionals …See details»
Metavention, Inc. - LinkedIn
Metavention, Inc. | 892 followers on LinkedIn. Together, we can effect real change in the treatment of metabolic disease. | Headquartered in Minneapolis, Minnesota, Metavention, Inc. is a...See details»
Clinical Studies - Metavention
Metavention is conducting clinical studies for patients with high blood pressure. If you or someone you care about is interested in pursuing an alternative to current treatments, answer the questions below and click on Am I A Candidate to take …See details»
Metavention - Crunchbase Company Profile & Funding
Metavention develops medical devices to help with interventional therapies for high blood pressure and other metabolic diseases. View contacts for Metavention to access new leads …See details»
Metavention Company Profile 2024: Valuation, Funding
Metavention was founded in 2012. Where is Metavention headquartered? Metavention is headquartered in Maple Grove, MN. What is the size of Metavention? Metavention has 18 total …See details»
Metavention - The Org
Metavention is a privately held medical device company developing novel treatments for metabolic diseases.See details»
Metavention Announces Initiation of U.S. Clinical Trial for Novel ...
MINNEAPOLIS, Feb. 17, 2021 /PRNewswire/ -- Metavention, Inc. announces the initiation of an FDA-approved clinical investigation, DeLIVER (NCT04285554), for the Company's …See details»
Metavention - Products, Competitors, Financials, Employees ...
Metavention is a medical device company focused on developing treatments for metabolic diseases. The company's main offering is a minimally invasive procedure using the iRF …See details»
Metavention - Versant Ventures
Metavention seeks to develop a safe and effective treatment that can aid patients with type 2 diabetes who are struggling to control their blood sugar with lifestyle modification and non …See details»
Focus - Metavention
Innovative solutions to big challenges. The sympathetic nervous system plays an important role in regulating our metabolism by delivering information between our brain and the organs that control daily changes in our body’s energy needs.See details»
Metavention Company Profile - Office Locations, Competitors
Metavention is a medical device company developing treatments for metabolic diseases. It provides a glucose control therapy for patients with type 2 diabetes. Metavention has 5 …See details»
Metavention Announces Initiation of Groundbreaking Multi-Organ ...
MINNEAPOLIS, May 3, 2021 /PRNewswire/ -- Metavention, Inc. announces the initiation of the MODUS Study (ACTRN12620000412932), to treat patients with both type 2 diabetes and …See details»
Metavention Completes U.S. Enrollment in ... - Markets Insider
Jan 5, 2022 · Metavention, Inc. is a privately held medical device company headquartered in Maple Grove, Minnesota, and the developer of the iRF Denervation System. Metavention's …See details»
Metavention raises $65m to tackle diabetes with metabolic ...
Jan 9, 2018 · Abnormally high blood glucose levels in people with diabetes have been associated with an overactive sympathetic nervous system, according to Metavention. The Minneapolis …See details»
Metavention Company Profile: Overview and Full News Analysis
Metavention is dedicated to developing groundbreaking treatments for high blood pressure and metabolic diseases. Their iRF Denervation System offers a minimally invasive procedure for …See details»
Blog - Metavention
Feb 24, 2017 · Metavention’s Renal Denervation Pivotal IDE Study now Approved by FDA for the Treatment of Hypertension. Jun 21, 2023; Read MoreSee details»
Metavention - Funding, Financials, Valuation & Investors
Metavention develops medical devices to help with interventional therapies for high blood pressure and other metabolic diseases.See details»
Metavention Completes U.S. Enrollment in Groundbreaking …
MINNEAPOLIS, Jan. 5, 2022 /PRNewswire/ -- Metavention, Inc. announces the completion of enrollment in the DeLIVER U.S. Study (NCT04285554), to evaluate the safety of sympathetic …See details»
Early Feasibility of the Metavention Integrated Radio Frequency …
Sep 26, 2019 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help …See details»